

(Alliance News) - C4X Discovery Holdings PLC on Thursday said it has completed its preclinical study showing that its MALT-1 lead compounds are free o...


(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Wednesday and not separately reported by Allia...


(Alliance News) - C4X Discovery Holdings PLC on Wednesday launched PatientSeek, a precision medicine platform for patient stratification based on gene...


(Sharecast News) - C4X Discovery launched a new precision medicine platform called 'PatientSeek' on Wednesday, after a successful research collaborati...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:


(Sharecast News) - C4X Discovery updated on its 'MALT-1' inhibitor programme on Thursday, explaining that the overexpression or over-activation of MAL...